bendamustine Articles
Mundipharma's bendamustine plus rituximab doubles PFS in non-Hodgkin lymphoma and MCL patients
20 February 2013
Lundbeck gets marketing OK for Treanda in Canada
29 August 2012
Lundbeck to expand opportunities in Canada and Latin America with Cephalon products
10 February 2011
US FDA warns four drugmakers on inaccurate promotion
13 January 2010
Cephalon swings back to profit in 3rd qtr
1 December 2008
Expanded indication for Cephalon
10 November 2008
US FDA set for even fewer approvals in 2008
1 September 2008
Cephalon exceeds guidance for 2nd qtr
11 August 2008
Stock Commentary - New York week to March 24, 2008
31 March 2008
FDA clears Cephalon's Treanda for CLL
31 March 2008
FDA Treanda decision expected end-October
25 February 2008
Cephalon seeks NHL indication for Treanda
7 January 2008
Strong Ph III data for Cephalon's Treanda
5 November 2007
US orphan status for Cephalon's Treanda for CLL
10 September 2007
Cephalon plans to file Treanda NDA in 3rd qtr
9 July 2007
Cephalon sees 19% sales jump in 2nd qtr
15 August 2005
Cephalon buys into cancer therapy sector
20 June 2005
Cephalon to buy Salmedix for $160M
23 May 2005
Showing 1-19 of 19 articles
- 1
- Is failure to adopt business process management putting the pharma industry at risk?
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- New Zealand declines Alexion's funding application for Solaris
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
